氯膦酸鹽脂質(zhì)體JEM期刊缺血再灌注模型外周血單核巨噬細胞清除解決方案
中文摘要:
以前的研究表明神經(jīng)元引導(dǎo)分子 netrin-1 有助于減輕心肌缺血再灌注損傷。然而,組織特異性來源和受體信號轉(zhuǎn)導(dǎo)事件仍然難以捉摸。中性粒細胞是最早對缺血性損傷做出反應(yīng)的細胞之一,可能與組織損傷或救援有關(guān)。我們發(fā)現(xiàn)心肌梗死患者血液中 netrin-1 水平升高,以及暴露于心肌缺血再灌注的小鼠。在 Ntn1loxP/loxP Lyz2 Cre+ 小鼠中發(fā)現(xiàn)選擇性增加的梗死面積和肌鈣蛋白水平,但在其他組織區(qū)室中條件性 netrin-1 缺失的小鼠中沒有發(fā)現(xiàn)。使用中性粒細胞耗竭的體內(nèi)研究確定,中性粒細胞是心肌損傷期間血液 netrin-1 升高的主要來源。最后,使用重組 netrin-1 治療的藥理學(xué)研究揭示了通過髓樣腺苷 A2b 受體的嘌呤能信號事件在介導(dǎo) netrin-1 誘導(dǎo)的心臟保護中的功能作用。這些發(fā)現(xiàn)表明,中性粒細胞來源的 netrin-1 在通過髓系腺苷 A2b 信號傳導(dǎo)減輕心肌缺血再灌注損傷中具有功能作用的自分泌信號回路。
英文摘要:
Previous studies implicated the neuronal guidance molecule netrin-1 in attenuating myocardial ischemia-reperfusion injury. However, the tissue-specific sources and receptor signaling events remain elusive. Neutrophils are among the first cells responding to an ischemic insult and can be associated with tissue injury or rescue. We found netrin-1 levels were elevated in the blood of patients with myocardial infarction, as well as in mice exposed to myocardial ischemia-reperfusion. Selectively increased infarct sizes and troponin levels were found in Ntn1loxP/loxP Lyz2 Cre+ mice, but not in mice with conditional netrin-1 deletion in other tissue compartments. In vivo studies using neutrophil depletion identified neutrophils as the main source for elevated blood netrin-1 during myocardial injury. Finally, pharmacologic studies using treatment with recombinant netrin-1 revealed a functional role for purinergic signaling events through the myeloid adenosine A2b receptor in mediating netrin-1–elicited cardioprotection. These findings suggest an autocrine signaling loop with a functional role for neutrophil-derived netrin-1 in attenuating myocardial ischemia-reperfusion injury through myeloid adenosine A2b signaling.
論文信息:
論文題目: PMN-derived netrin-1 attenuates cardiac ischemia-reperfusion injury via myeloid ADORA2B signaling
期刊名稱:JEM- J Exp Med
時間期卷:J Exp Med (2021) 218 (6): e20210008.
在線時間:2021年4月23日
DOI: //doi.org/10.1084/jem.20210008
Liposoma巨噬細胞清除劑Clodronate Liposomes見刊于JEM:
Liposoma巨噬細胞清除劑Clodronate Liposomes氯膦酸二鈉脂質(zhì)體的材料和方法:
JEM期刊缺血再灌注模型外周血單核巨噬細胞清除解決方案
Monocyte and macrophage depletion
Mice were given 100 µl/10 g body weight i.v. clodronate liposomes (Liposoma BV) 24 h before surgery to deplete monocytes and macrophages as described before . Control mice received liposomes only at the same time points.
相關(guān)產(chǎn)品
免責(zé)聲明
- 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品,未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關(guān)法律責(zé)任。
- 本網(wǎng)轉(zhuǎn)載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點和對其真實性負(fù)責(zé),不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個人從本網(wǎng)轉(zhuǎn)載時,必須保留本網(wǎng)注明的作品第一來源,并自負(fù)版權(quán)等法律責(zé)任。
- 如涉及作品內(nèi)容、版權(quán)等問題,請在作品發(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。